COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101544 · Cited by 2,397

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Haas, E. J., Angulo, F. J., McLaughlin, J. M., Anis, E., Singer, S. R., Khan, F., Brooks, N., Smaja, M., Mircus, G., Pan, K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00947-8 · Cited by 1,564

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H. L., Yoon, S. K., Meece, J., Olsho, L. E. W., Caban-Martinez, A. J., Fowlkes, A., Lutrick, K., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7013e3 · Cited by 707

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Tenforde, M. W., Olson, S. M., Self, W. H., Talbot, H. K., Lindsell, C. J., Steingrub, J. S., Shapiro, N. I., Ginde, A. A., Douin, D. J., Prekker, M. E., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7018e1 · Cited by 286

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021

Wallace, M. M., Woodworth, K. R., Gargano, J. W., Scobie, H. M., Blain, A. E., Moulia, D., Chamberland, M. E., Reisman, N., Hadler, S. C., MacNeil, J. R., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7020e1 · Cited by 141

Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2

Paden, C. R., Tao, Y., Queen, K. J., Zhang, J., Li, Y., Uehara, A., & Tong, S. (2020) · Emerging infectious diseases · doi:10.3201/eid2610.201800 · Cited by 135

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening

Tande, A. J., Pollock, B. D., Shah, N. D., Farrugia, G., Virk, A., Swift, M., Breeher, L., Binnicker, M., & Berbari, E. F. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab229 · Cited by 120

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Swift, M. D., Breeher, L. E., Tande, A. J., Tommaso, C. P., Hainy, C. M., Chu, H., Murad, M. H., Berbari, E. F., & Virk, A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab361 · Cited by 98

Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations?

Kanakan, A., Mehta, P., Devi, P., Saifi, S., Swaminathan, A., Maurya, R., Chattopadhyay, P., Tarai, B., Das, P., Jha, V., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.763169 · Cited by 6

Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review

Murton, M., Drane, E., Jarrett, J., Cornely, O. A., & Soriano, À. (2022) · Infection · doi:10.1007/s15010-022-01930-8 · Cited by 6

Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection

Simayi, A., Li, C., Chen, C., Wang, Y., Dong, C., Tian, H., Kong, X., Zhou, L., Peng, J., Zhang, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1083523 · Cited by 6

Role of Mass Media and Public Health Communications in COVID-19 Vaccination

Anwar, A., Malik, M., Raees, V., Anwar, M., & Anwar, A. (2023) · Medical Research Archives · doi:10.18103/mra.v11i2.3544 · Cited by 6

Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan

Sayeed, M. A., Shalim, E., Farooqui, F., Farman, S., Khan, M., Iqbal, A., Ahmed, I., Rajput, A. W., Razzaque, A., & Quraishy, S. (2023) · Vaccines · doi:10.3390/vaccines11071178 · Cited by 6

A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections

Liu, J., Wen, R., Wang, N., Li, G., Xu, P., Li, X., Zeng, X., & Liu, C. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.87167 · Cited by 6

Reinfection and Breakthrough Infection of SARS-CoV-2: An Emerging Challenge That Is Threatening Our World

Gao, L., Mu, X., Jiao, Y., & Wang, F. (2021) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000027 · Cited by 6

Real-world effectiveness of COVID-19 vaccination in liver cirrhosis: a systematic review with meta-analysis of 51,834 patients

Beran, A., Mhanna, A. S., Mhanna, M., Hassouneh, R., Abuhelwa, Z., Mohamed, M. F. H., Sayeh, W., Musallam, R., Assaly, R., & Abdeljawad, K. H. (2023) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2023.2165344 · Cited by 6

A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning

Patel, M. A., Daley, M. J., Nynatten, L. V., Slessarev, M., Cepinskas, G., & Fraser, D. D. (2024) · Clinical Proteomics · doi:10.1186/s12014-024-09488-3 · Cited by 5

Clinical characteristics and outcome of hospitalized elderly patients with COVID- 19 after vaccine failure

Díaz‐Menéndez, M., Calle, F., Montejano, R., Arsuaga, M., Jiménez-González, M., Pérez-Blanco, V., Marcelo, C., Vasquez-Manau, J., Lázaro, F., & Arribas, J. R. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.003 · Cited by 6

SARS-CoV-2 transmission dynamics in bars, restaurants, and nightclubs

van der Veer, B. M. J. W., Gorgels, K. M. F., den Heijer, C. D. J., Hackert, V., van Alphen, L. B., Savelkoul, P. H. M., Hoebe, C. J. P. A., & Dingemans, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1183877 · Cited by 7

Breakthrough COVID-19 infections and perceived vaccine effectiveness

Neely, S. R., & Hao, F. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.11.032 · Cited by 5

Mathematical Modeling of COVID‐19 Disease Dynamics With Contact Tracing: A Case Study in Ethiopia

Zerefe, S. B., Ayele, T. K., & Tilahun, S. L. (2024) · Journal of Applied Mathematics · doi:10.1155/2024/5556734 · Cited by 5

Transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2), delta variant, between two fully vaccinated healthcare personnel

Smith, L., Milstone, A. M., Jibowu, M., Luo, C. H., Morris, C. P., Mostafa, H. H., & Maragakis, L. L. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.469 · Cited by 5

Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines

Brunner‐Ziegler, S., Spath, T., Kornek, G. V., König, F., Parschalk, B., Schnetzinger, M., Straßl, R. P., Savic, R., Foit, A., Resch, H., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.023 · Cited by 5

Examining the impact of COVID-19 vaccination rates on differential access to critical care

Cromley, G. A., & Lin, J. (2022) · Applied Geography · doi:10.1016/j.apgeog.2022.102751 · Cited by 5

Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States Before the Delta- and Omicron-Associated Surges: A Retrospective Cohort Study of Repeat Blood Donors

Grebe, E., Yu, E. A., Bravo, M. D., Welte, A., Bruhn, R. L., Stone, M., Green, V., Williamson, P. C., Feldstein, L. R., Jones, J. M., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac318 · Cited by 5

Embitterment during the COVID-19 Pandemic in Reaction to Injustice, Humiliation, and Breach of Trust

Linden, M., Arnold, C. P., & Muschalla, B. (2022) · Psychiatry International · doi:10.3390/psychiatryint3030016 · Cited by 5

Impact of Vaccination and Control Measures on the Fatality of COVID-19: An Ecological Study

Tan, J., Wu, Z., Gan, L., Zhong, Q., Zhu, Y., Li, Y., & Zhang, D. (2022) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-022-00064-2 · Cited by 5

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients

Zhang, X., Weng, R., Liu, F., Xie, Y., Jin, Y., Li, Q., Huang, G., Chen, J., Wang, J., Shen, H., et al. (2022) · Vaccines · doi:10.3390/vaccines10111911 · Cited by 5

Better Metrics to Guide Public Health Policy: Lessons Learned From COVID-19 for Data Systems Improvement

Stoto, ­. A., Kraemer, J. D., & Piltch-Loeb, R. N. (2023) · Harvard Data Science Review · doi:10.1162/99608f92.3e516c04 · Cited by 5

Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19

Ameratunga, R., Mears, E., Leung, E. Y., Snell, R. G., Woon, S., Kelton, W., Medlicott, N. J., Jordan, A., Abbott, W. G. H., Steele, R. H., et al. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad096 · Cited by 5

The importance of time post-vaccination in determining the decrease in vaccine efficacy against SARS-CoV-2 variants of concernPreprint

Bar‐On, Y. M., Noor, Ε., Gottlieb, N., Sigal, A., & Milo, R. (2021) · medRxiv · doi:10.1101/2021.06.06.21258429 · Cited by 4

COVID-19 convalescent plasma donors: impact of vaccination on antibody levels, breakthrough infections and reinfection ratePreprint

Raja, M. L., Pacenti, M., Ileana, G., Boldrin, C., Cattai, M., Erica, S., Anna, B., Michele, S., Alberto, R., Rosa, L. A., et al. (2021) · medRxiv · doi:10.1101/2021.07.13.21260414 · Cited by 5

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?

Krueger, K., Halasa, N., & Ison, M. G. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.10.003 · Cited by 5

An elite broadly neutralizing antibody protects SARS-CoV-2 Omicron variant challengePreprint

Zhou, B., Zhou, R., Chan, J. F., Luo, M., Peng, Q., Yuan, S., Mok, B. W.-Y., Chen, B., Wang, P., Poon, V. K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.05.475037 · Cited by 5

GAME-THEORETICAL MODEL OF COVID-19 VACCINATION IN THE ENDEMIC EQUILIBRIUM

MARQUEZ, R. M. A., MINAS, M. S. C., Santos, J., Yoon, K. H., CAMPO, V. N. S., Oh, H.-J., Rychtář, J., & Taylor, D. (2023) · Journal of Biological Systems · doi:10.1142/s021833902450013x · Cited by 4

An integrated theoretical study on natural alkaloids as SARS-CoV-2 main protease inhibitors: a step toward discovery of potential drug candidates with anti-COVID-19 activity

Parveen, S., Shahbaz, L., Shafiq, N., Rashid, M., Mohany, M., & Zhu, M. (2025) · RSC Advances · doi:10.1039/d4ra06536k · Cited by 4

SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May–June 2021

Harris, J. R., Owusu, D., O’Laughlin, K., Cohen, A. L., Hamida, A. B., Patel, J. C., Freeman, M. M., Nsibambi, T., Nieves, R., Marston, B. J., et al. (2022) · Emerging infectious diseases · doi:10.3201/eid2806.220427 · Cited by 4

At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers

Humphreys, D. P., Gavin, K. M., Olds, K. M., Bonaca, M. P., & Bauer, T. A. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07377-4 · Cited by 4

The impact of COVID-19 vaccination on California’s return to normalcy

Daza–Torres, M. L., García, Y. E., Schmidt, A. J., Pollock, B. H., Sharpnack, J., & Nuno, M. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264195 · Cited by 4

Profile and Outcomes of Hospitalized COVID-19 Patients during the Prevalence of the Omicron Variant According to the Brazilian Regions: A Retrospective Cohort Study from 2022

Drummond, P. D., de Salles, D. B., de Souza, N. S. H., de Oliveira, D. C. R., Guidoni, D. L., & de Souza, F. S. H. (2023) · Vaccines · doi:10.3390/vaccines11101568 · Cited by 3

Epidemiology, clinical features and outcomes of hospitalized patients with COVID-19 by vaccination status: a multicenter historical cohort study

Alshanqeeti, S., Szpunar, S. M., Anne, P., Saravolatz, L. I. I., & Bhargava, A. (2024) · Virology Journal · doi:10.1186/s12985-024-02325-x · Cited by 4

Molecular accuracy vs antigenic speed: SARS-CoV-2 testing strategies

Fajardo, Á., Perbolianachis, P., Ferreiro, I., Moreno, P., & Moratorio, G. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.12.006 · Cited by 4

A Retrospective Cross-Sectional Study of Severe Breakthrough SARS-CoV-2 Infection in the General Population Requiring Hospitalization Within a Single Health System

Acharya, R., Kafle, S., KANDINATA, N. N., Slipman, B., Ghimire, M., & Trotter, A. B. (2022) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4662 · Cited by 4

An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic

Hijano, D. R., Hoffman, J. M., Tang, L., Schultz‐Cherry, S., Thomas, P. G., Hakim, H., Webby, R. J., Hayden, R. T., Gaur, A. H., & St. Jude COVID-19 Employee Screening Program Team (2022) · PLoS ONE · doi:10.1371/journal.pone.0268237 · Cited by 4

Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19

Lee, C. M., Choe, P. G., Kang, C. K., Lee, E., Song, K., Bang, J. H., Kim, E. S., Kim, H. B., Kim, N. J., Kim, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1106664 · Cited by 4

Management of SARS-CoV-2 and Persistent Viral Detection in Solid Organ Transplant Recipients

de Castro, K. L. P., Naik, C. A., Spak, C. W., Askar, M. Z., Pittmon, L., Williams, J. D., Vandervest, K., Endicott-Yazdani, T. R., Grazia, T. J., Gottlieb, R., et al. (2024) · Current Pulmonology Reports · doi:10.1007/s13665-024-00338-z · Cited by 4

COVID-19 Breakthrough Infections Among People With HIV: A Statewide Cohort Analysis

Yang, X., Zhang, J., Chen, S., Liu, Z., Poland, G. A., Olatosi, B., Weissman, S., & Li, X. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003475 · Cited by 4

Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan

Rizwan, W., Qureshi, A. U., Rana, M. N., Duggal, M. N., Sohaib, M., & Sadiq, M. (2022) · Annals of King Edward Medical University · doi:10.21649/akemu.v27i4.4884 · Cited by 4

Epidemiological characteristics and quarantine assessment of imported international COVID-19 cases, March to December 2020, Chengdu, China

Zhang, W., Yue, Y., Min, H., Du, C., Wang, C., Tuo, X., Jiang, X., Fan, S., Chen, Z., Chen, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20712-8 · Cited by 4

Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021

Yadav, P. D., Sahay, R. R., Agrawal, S. R., Shete, A. M., Adsul, B. B., Tripathy, S. P., Nyayanit, D. A., Manrai, M., Patil, D. Y., Kumar, S., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.04.014 · Cited by 4

Managing Candida auris in dialysis units: challenges, strategies, and future directions

Zoi, V., Skoulatou, M., Vassilikopoulos, T., & Vovlianou, S. (2025) · International Urology and Nephrology · doi:10.1007/s11255-025-04600-4 · Cited by 4

The Factors Associated with the Development of COVID-19 Symptoms among Employees in a U.S. Healthcare Institution

Abu-Alhaija, D. M., Matibiri, P., Brittingham, K., Wulsin, V., Davis, K. G., Huston, T. R., & Gillespie, G. L. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20126100 · Cited by 3

SARS-COV-2 breakthrough infection and its covariates among healthcare providers of a hospital in Bangladesh during the omicron wave

Akhter, M., Roy, S. K., Khair, A., Karim, M. R., Mojlish, U. K. F. K., Ahmed, M. U., & Ali, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37287 · Cited by 3

Prevalence of COVID-19 Vaccine Hesitancy Among Healthcare Workers in Nigeria: A Systematic Review and Meta-Analysis

Abaate, T. J., Buowari, D. Y., Agiri, U. A., Inimgba, T., Ogbonna, V. I., Onyeaghala, C. A., Worgu, G. O., Somiari, A., Ezebuiro, E. I., & Onuah, I. A. (2025) · International Journal of Public Health · doi:10.3389/ijph.2025.1607655 · Cited by 3

COVID-19 Vaccine Effectiveness in a Diverse Urban Health Care Worker Population

Iliaki, E. F., Lan, F., Christophi, C. A., Guidotti, G., Jobrack, A. D., Buley, J., Nathan, N., Osgood, R. A., Bruno‐Murtha, L. A., & Kales, S. N. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.10.005 · Cited by 3

SARS-CoV-2 Infections among Vaccinated Patients on Maintenance Dialysis, January 1–August 31, 2021, United States

Bardossy, A. C., Angeles, J., Booth, S., Fike, L. V., Wadley, A., Rha, B., Lacson, E. K., Jr., Manley, H. J., Johnson, D. S., Apata, I. W., et al. (2022) · Kidney360 · doi:10.34067/kid.0003092022 · Cited by 3

COVID-19 in elderly: Correlations of viral load, clinical course, laboratory parameters, among patients vaccinated with CoronaVac

Altıntop, S. E., Ünalan-Altıntop, T., Cihangiroğlu, M., Onarer, P., Sezgin, F. M., Gözükara, M. G., GÖZÜKARA, B., & Zengin, E. (2022) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2022.01849 · Cited by 3

Reflections on the Social Determinants of the COVID-19 Vaccination Programme in Zimbabwe

Muridzo, N. G., Simbine, S. L., Simango, T., & Matanga, A. A. (2023) · Journal of Human Rights and Social Work · doi:10.1007/s41134-023-00240-9 · Cited by 3

Comparing the recurrence of audio-vestibular disorders following breakthrough infection of COVID-19 vs. those following vaccine administration

Wang, C., & Young, Y. (2023) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2023.103970 · Cited by 3

N-acetylcysteine as adjuvant therapy for hospitalized Covid-19 patients: A single-center prospective cohort study.

Afaghi, S., Moghimi, N., Alamdari, N. M., Rahimi, F. S., Irilouzadian, R., Tarki, F. E., Moghimi, M., Besharat, S., Omran, H. S., & Karimi, A. (2023) · PubMed Central · doi:10.22088/cjim.14.3.553 · Cited by 3

Impacts of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review

Bocquet-Garçon, A. (2024) · Cureus · doi:10.7759/cureus.57008 · Cited by 4

Estimating the Relative Risks of Spatial Clusters Using a Predictor–Corrector Method

Bani-Yaghoub, M., Rekab, K., Pluta, J., & Tabharit, S. (2025) · Mathematics · doi:10.3390/math13020180 · Cited by 3

Silent SARS-CoV-2 Infections, Waning Immunity, Serology Testing, and COVID-19 Vaccination: A Perspective

Narasimhan, M., Mahimainathan, L., Noh, J., & Muthukumar, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730404 · Cited by 3

SARS-CoV-2 immunity and an overview of the COVID-19 vaccines

Marković, M. (2021) · Medicinski podmladak · doi:10.5937/mp72-33315 · Cited by 3

To Boost or Not to Boost: Acceptability of a COVID-19 Booster Dose among Osteopathic Medical Students: A Cross-Sectional Study from a Medical School in New York

Janabi, T. A., & Pino, M. A. (2022) · Epidemiologia · doi:10.3390/epidemiologia3020017 · Cited by 3

Epidemiological and clinical characteristics of SARS-CoV-2 reinfections in a Spanish region

Yuguero, O., Companys, M., Guzmán, M., Maciel, R., Llobet, C., López, A., Olles, R., Pujol, V., Ruiz, M. J. H., Saura, M., et al. (2022) · SAGE Open Medicine · doi:10.1177/20503121221108556 · Cited by 3

COVID-19–Positive Testing in Minnesota High School Fall and Winter Sports: A Guide for Sports Risk

Roberts, W. O., Stuart, M. J., Lee, J. A., & Miner, M. H. (2021) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000001008 · Cited by 3

Large-Scale Implementation of a Daily Rapid Antigen Testing Program in California for Detecting SARS-CoV-2

Ventura, M. I., Delgado, D., Velasquez, S., Foote, E. M., Jacobson, K., Arguello, J. C., & Warburton, K. (2022) · American Journal of Public Health · doi:10.2105/ajph.2021.306588 · Cited by 3

Actions and attitudes on the immunized patients against SARS-CoV-2

Ramos, P. D. L., Botella, A. G., García‐Lledó, A., Gómez‐Pavón, J., del Castillo, J. M. G., Hernández‐Sampelayo, T., Delgado, M. C. M., Martín‐Sánchez, F. J., Martínez‐Sellés, M., Molero, J., et al. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/131.2021 · Cited by 3

Proactive COVID-19 testing in a partially vaccinated populationPreprint

McGee, R. S., Homburger, J. R., Williams, H., Bergstrom, C. T., & Zhou, A. Y. (2021) · medRxiv · doi:10.1101/2021.08.15.21262095 · Cited by 3

Rate of Recovery and Symptomatic Efficacy of a Polyherbal AYUSH Formulation in the Treatment of SARS CoV-2 disease: A Single-arm trialPreprint

Kanchibhotla, D., Harsora, P., Subramanian, S., reddy, R., & Hari Venkatesh, K. R. (2021) · Research Square · doi:10.21203/rs.3.rs-923003/v2 · Cited by 3

Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody LevelsPreprint

Abedi, M. R., Dixon, S. L., Guyon, T., Hsu, S., Jacobs, A. R., Nair, L. J., & Terbrueggen, R. H. (2021) · medRxiv · doi:10.1101/2021.10.13.21264921 · Cited by 3

CRISPR and COVID-19: Lessons Learned to Prepare for the Next Pathogen

Bond, J. C. (2022) · Georgetown Scientific Research Journal · doi:10.48091/gsr.v2i1.29 · Cited by 2

The effect of pandemic prevalence on the reported efficacy of SARS-CoV-2 vaccines

Sharma, R., & Anand, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266271 · Cited by 2

Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study

Abdelhamid, M. H. M., Almsellati, I. A., Annajar, B. B., Abdulhamid, A., Alemam, H. A., & Etikar, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276425 · Cited by 2

Evaluation of the Effectiveness of Immunization Saint-Petersburg Population against COVID-19

Daryina, M. G., Lubimova, A. V., Svetlichnaya, J. S., Сергеевна, З. А., Jazenok, A. V., Михайловна, Х. С., & Aslanov, B. I. (2022) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2022-21-5-21-28 · Cited by 2

Detrimental Effects of COVID-19 Measures on Mental Health and Social-Economic Disparities

Wang, H., & Sanchuli, N. (2022) · International Journal of Mental Health Promotion · doi:10.32604/ijmhp.2022.022319 · Cited by 2

Evaluating Policies to Decrease the Risk of Introducing SARS-CoV-2 Infections to Nursing Home Facilities

Adams, J. W., Jones, K., Preiss, S., Hadley, E., & Segelman, M. (2023) · Journal of Applied Gerontology · doi:10.1177/07334648231155873 · Cited by 2

Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity

Yu, E. A., Jackman, R. P., Glesby, M. J., & Narayan, K. V. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.06.003 · Cited by 2

Incidence of breakthrough infections after COVID-19 vaccination among the COVID-19 vaccine recipients at a Tertiary Care Hospital in Srinagar

Ain, S. N., Fazili, A. B., Shah, R. J., Raja, F., Farhat, D., & Nazir, I. (2023) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_1403_22 · Cited by 1

Breakthrough COVID-19 infections – Analyzing our experience

Hussain, A. N., Sarfaraz, S., Anis, S., Shaikh, Q., Rahim, A., Khan, S. B., Shah, R., & Khan, O. (2023) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.39.5.6724 · Cited by 2

VAX SAVVY: EXPLORING KNOWLEDGE, AWARENESS, AND PERCEPTIONS OF COVID-19 VACCINES AMONG VACCINATED STUDENTS

Othman, M. I., Sulaiman, S., & Najib, M. N. M. (2023) · Asian People Journal (APJ) · doi:10.37231/apj.2023.6.2.545 · Cited by 2

Enhancing Performance of Libyan, Traditional Medicine: Comprehensive Survey Insights During the COVID-19 Pandemic

Kamoka, H. M. E., & Elengoe, A. (2023) · Mağallaẗ ʻulūm al-rāfidayn · doi:10.33899/rjs.2023.181263 · Cited by 2

The Moderating Role of Anxiety and Depressive Symptoms in Protective Effects of Health Behaviors among Clients Using Mental Health Services

Zhai, Y., Almaawali, M. S., & Du, X. Y. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061753 · Cited by 2

Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls

Eviatar, T., Pappo, A., Freund, T., Friedlander, Y., Elkayam, O., Hagin, D., & Heshin‐Bekenstein, M. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae044 · Cited by 2

Genome-Wide Association Study of COVID-19 Breakthrough Infections and Genetic Overlap with Other Diseases: A Study of the UK Biobank

Feng, Y., Wong, K. C.-Y., Tsui, W.-K., Zhang, R., Xiang, Y., & So, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136441 · Cited by 1

Clinical performance evaluation of BD SARS-CoV-2 reagents for BD MAXTM System in asymptomatic individuals

Yanson, K. A., LaViers, W. D., Suhaidi, F., Greeley, Z., Merryman, C., Proctor, R., Hall, D., & Neely, L. A. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115861 · Cited by 2

Analysis of a COVID-19 Prescreening Process in an Outpatient Clinic at a University Hospital during the COVID-19 Pandemic

Choi, U. Y., Jung, S. E., Kim, M. S., Oh, H. S., Kwon, Y. M., Lee, J., & Choi, J. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e295 · Cited by 2

Emergence of Omicron BA.1 and BA.2 variants and concern over vaccine breakthrough infection

Sukaina, M., Ali, N., Waheed, M., Hasan, M. M., & Essar, M. Y. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103941 · Cited by 2

Applying Regressive Machine Learning Techniques in Determination of COVID-19 Vaccinated Patients’ Influence on the Number of Confirmed and Deceased Patients

Šegota, S. B., Lorencin, I., Anđelić, N., Musulin, J., Štifanić, D., Glučina, M., Vlahinić, S., & Car, Z. (2022) · Mathematics · doi:10.3390/math10162925 · Cited by 2

Effect on the conformations of the spike protein of SARS‐CoV‐2 due to mutation

Gupta, A. M., & Chakrabarti, J. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2413 · Cited by 2

Profile of COVID-19 breakthrough cases and its comparison with unvaccinated COVID-19 cases among healthcare workers in a tertiary care centre in North Kerala

Rajasi, R. S., Chandran, P., Sivakumar, C., George, B., Amrutha, D., Elizabeth, M., & George, A. M. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1725_22 · Cited by 2

Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

Ahmed, S., Gupta, L., Kuwana, M., Pauling, J. D., Day, J. A., Ravichandran, N., Joshi, M. M., Parodis, I., Sen, P., Jagtap, K., et al. (2023) · Rheumatology International · doi:10.1007/s00296-023-05433-z · Cited by 2

Determining the impact of vaccination on SARS-CoV-2 RT-PCR cycle threshold values and infectious viral titres

Peterson, K. L., Snyder, J. P., Despres, H. W., Schmidt, M. M., Eckstrom, K. M., Unger, A. L., Carmolli, M. P., Sevigny, J. L., Shirley, D. J., Dragon, J. A., et al. (2023) · Access Microbiology · doi:10.1099/acmi.0.000597.v3 · Cited by 2

Community-Based Phenotypic Study of Safety, Tolerability, Reactogenicity and Immunogenicity of Emergency-Use-Authorized Vaccines Against COVID-19 and Viral Shedding Potential of Post-Vaccination Infections: Protocol for an Ambispective studyPreprint

Gabashvili, I. S. (2021) · medRxiv · doi:10.1101/2021.06.28.21256779 · Cited by 1

Post-Vaccination Symptomatic SARS-CoV-2 Infections are Minimal and Non-Serious: An Observational Multicenter Indian Cohort Study of 28342 Healthcare WorkersPreprint

Vaishya, R., Sibal, A., Malani, A., Kar, S., Hari Prasad, K., Kiran, S. V., Reddy, S., Kamineni, S., Reddy, S., Reddy, P. A., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3889352 · Cited by 2

Correlates of and barriers to COVID-19 vaccine initiation and intention among US college students

Kollath‐Cattano, C., Hatteberg, S. J., Petillo, S. L., & Giancaterini, M. (2023) · Journal of American College Health · doi:10.1080/07448481.2023.2222843 · Cited by 1

Neurological disorders throughout acute SARS-CoV2 infection: A comparative study between vaccinated and non-vaccinated patients

Cristillo, V., Pilotto, A., Piccinelli, S. C., Libri, I., Locatelli, M., Giunta, M., Mazzoleni, V., Pezzini, D., Arici, D., Gipponi, S., et al. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.122898 · Cited by 1

Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study

Violán, C., Quirant‐Sánchez, B., Palau-Antoja, M., Palacín, D., Pradenas, E., Trigueros, M., Pera, G., Molist, G., Fernández‐Rivas, G., Boigués, M., et al. (2025) · Vaccines · doi:10.3390/vaccines13070738 · Cited by 1

Risk of SARS-CoV-2 Reinfections Among Healthcare Workers of Four Large University Hospitals in Northern Italy: Results of an Online Survey Within the ORCHESTRA Project

Liviero, F., Volpin, A., Furlan, P., Cocchio, S., Baldo, V., Pavanello, S., Moretto, A., Gobba, F., Modenese, A., Mauro, M., et al. (2025) · Vaccines · doi:10.3390/vaccines13080815 · Cited by 2

Impact of ventilation and ambient temperature on COVID-19 transmission in clinic waiting rooms: A computational fluid dynamics approach

Zhu, Z., Gao, G., Hu, Y., & Zhao, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328154 · Cited by 1

Post-vaccination SARS-CoV-2 infections among healthcare workers in a tertiary hospital in Ghana

Marfoh, K., Samba, A., Okyere, E., Fattah, A. Z., Darko, D. N. A., Odoom, P. N., & Ashaley, M. D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331971 · Cited by 1

Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during the Delta-to-Omicron transition

Yuan, E., Hansen, C. L., Tamim, S., Kanwar, S., Spiro, D. J., González-Losa, R., Conde‐Ferráez, L., Granja-Pérez, P., Villanueva-Jorge, S., López-Martı́nez, I., et al. (2026) · mBio · doi:10.1128/mbio.02432-25 · Cited by 1

Mental health during COVID-19 through Online Photovoice (OPV) in China

Jiang, Y., Cheng, X., Tanhan, A., Francisco, V. T., Ulus, İ. Ç., Hauber‐Özer, M., & Zou, R. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1773369 · Cited by 1

COVID-19 Subclinical Infection and Immunity

Bartekwa, J. W., Abene, E., Luka, P. D., Yilgwan, C. S., & Shehu, N. Y. (2021) · Nigerian Journal of Medicine · doi:10.4103/njm.njm_85_21 · Cited by 1

Clinico-Epidemiological Characteristics of Healthcare Workers with SARS-CoV-2 Infection during the First and Second Waves in a Teaching Hospital from Eastern India: A Comparative Analysis

Singh, A. K., Panigrahi, M. K., Pradhan, S. K., Pal, D., Subba, S. H., Patro, B. K., Behera, B. K., Mishra, B., Behera, B., Mohapatra, P. R., et al. (2022) · Hospital Topics · doi:10.1080/00185868.2022.2096523 · Cited by 1

Pattern of Chest X-rays findings and clinical correlation with the severity in COVID-19 (RT-PCR positive) infected patients admitted in a COVID-19 dedicated hospital in Bangladesh

Biswas, N. K., Chowdhury, J., Rita, M., Yesmin, M., Biswas, P., Aziz, A. M., & Shil, T. C. (2022) · Bangladesh Journal of Medicine · doi:10.3329/bjm.v33i3.61375 · Cited by 1

Impact of COVID-19 vaccines on the health status of young female adults from India: A cross-sectional study

Silwal, K., Kodali, P. B., Sharma, H., Tewani, G. R., & Nair, P. M. K. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1574_22 · Cited by 2

Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021

Kugeler, K. J., Williamson, J., Curns, A. T., Healy, J. M., Nolen, L. D., Clark, T. A., Martin, S. W., & Fischer, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264179

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19

Parums, D. V. (2021) · Medical Science Monitor · doi:10.12659/msm.935624 · Cited by 4

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness

Reynolds, M. W., Xie, Y., Knuth, K. B., Mack, C. D., Brinkley, E., Toovey, S., & Dreyer, N. A. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1

The impact of vaccination on COVID-19

Shamama, F., Zhamutashvili, M., Dolmazashvili, E., Badridze, N., Gognadze, T., & Sharvadze, L. (2023) · Journal of Biomedical and Medical Sciences · doi:10.51231/2667-9507-2023-002-01-62-66 · Cited by 1

POSC419 Examining the Rate of COVID-19 Breakthrough Infections in Individuals Who Received mRNA Vaccine in the United States

Madge, V. J., Bhardwaj, N., & Mazumder, D. (2022) · Value in Health · doi:10.1016/j.jval.2021.11.1320